文献速递泌尿系结石

输尿管镜与体外冲击波碎石治疗成人输尿管结石<10mm的成本分析:英国视角

Cost analysis of ureteroscopy (URS) vs extracorporeal shockwave lithotripsy (ESWL) in the management of ureteric stones <10 mm in adults: a UK perspective.
PubMed 文献 · BJU Int · 2019-12-02

该研究基于NICE指南的系统评价与Meta分析,比较以输尿管镜(URS)或体外冲击波碎石(ESWL)起始的治疗策略的总成本。结果显示URS策略总体成本更高(增量成本2387英镑),即使ESWL初始成功率仅40%时URS仍更昂贵;探索性QALY分析表明ESWL需效果极低且等待后续治疗数周才可能值得URS额外成本,结论支持ESWL作为一线治疗。

要点

  • URS策略总体成本比ESWL策略高2387英镑。
  • 即使ESWL初始成功率降至40%,URS仍更昂贵。
  • ESWL初始结石清除率较低但成本优势明显,宜作为一线选择。

核心结论

  • ESWL初始结石清除效果低于URS且需更多辅助干预,但URS成本增量达2387英镑,在人群层面作为一线治疗不太可能具有成本效果,提示ESWL应为首选治疗。

研究设计与样本

  • 基于NICE指南的系统评价与Meta分析证据,开展成本分析,仅纳入患者达到无石状态且效果基于一线初始手术的研究。
  • 另进行探索性QALY分析,识别最昂贵干预具有成本效果所需的QALY与生活质量差异。

主要发现

  • URS策略总体成本高于ESWL策略,增量成本为2387英镑。
  • 敏感性分析将ESWL初始效果在基础值82%至40%间变动,URS仍为更昂贵策略,即使ESWL初始单次成功率仅40%。
  • 探索性QALY的双向敏感性分析显示,ESWL需效果极低且失败后等待进一步治疗数周,才可能获得足以证明URS额外成本合理的QoL增益。

关键数值与推荐

  • URS策略较ESWL策略增量成本为2387英镑。
  • ESWL初始效果基础值为82%,敏感性分析范围至40%。

临床怎么用

  • 对于成人<10mm输尿管结石,考虑以ESWL作为一线治疗策略以控制总体成本。
  • 选择URS时应权衡其较高初始无石率与再入院及不良事件带来的下游资源使用和成本增加。

局限性

  • NICE指南Meta分析显示研究间存在较大异质性且结局报告方式不同。
  • 成本分析仅纳入患者达到无石状态且效果基于一线初始手术的研究。
  • QALY分析为探索性工作,基于初始手术效果差异为主要QALY增益来源的假设。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare the total cost of a treatment strategy starting with ureteroscopy (URS) vs a strategy starting with extracorporeal shockwave lithotripsy (ESWL). METHODS: For ureteric stones of <10 mm, URS or ESWL are the main treatment options that are considered. Although the interventions differ, the goal of the interventions is to achieve a stone-free status. A systematic review and meta-analysis undertaken as part of the National Institute for Health and Care Excellence (NICE) guideline on 'Renal and ureteric stones: assessment and management' identified URS as more effective, in terms of getting people stone free, but has a higher probability of re-admission and adverse events (AEs) that contributes to downstream resource use. ESWL is initially less costly, but lower effectiveness means a greater need for repeat or ancillary procedures in order to get a patient stone free. Given these trade-offs between benefits and costs, a cost analysis of URS and ESWL was undertaken as part of the NICE guideline, using evidence from the literature of effectiveness, re-admission and AEs. The NICE guideline meta-analysis showed a lot of heterogeneity and differences in how outcomes were reported between studies. The costing analysis, therefore only used studies where: (i) patients were rendered stone free, and (ii) where effectiveness, was based on the first-line (initial) procedures. Exploratory quality adjusted life year (QALY) work was also undertaken to identify the QALY and quality of life (QoL) differences required for the most expensive intervention to be cost effective, based on the assumption that the difference in effectiveness between the initial procedures would be the main source of the QALY gain between the two strategies. RESULTS: The URS strategy was more costly overall than the ESWL strategy (incremental cost of £2387 [pounds sterling]). Sensitivity analysis varying the initial effectiveness of ESWL treatment (between the base case value of 82% and 40%) showed that URS would still be a more costly strategy even if the initial session of ESWL only had a success probability of 40%. A two-way sensitivity analysis as part of the exploratory QALY work showed that ESWL would have to have very low effectiveness and people would have to wait for further treatment for many weeks (following a failed ESWL treatment) for there to be feasible QoL gains to justify the additional cost of the URS strategy. CONCLUSIONS: ESWL is less effective at initial stone clearance and therefore requires more ancillary interventions than URS. However, the magnitude of the difference in costs means URS is unlikely to be cost effective intervention at a population level for first-line treatment, implying ESWL should be the first choice treatment.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Constanti M, Calvert RC, Thomas K, et al. Cost analysis of ureteroscopy (URS) vs extracorporeal shockwave lithotripsy (ESWL) in the management of ureteric stones <10 mm in adults: a UK perspective. BJU Int. 2019. PMID: 31663246. doi:10.1111/bju.14938

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。